Antitrust Proceedings and Industry Dynamics
In 1940, the United States Department of Justice filed an antitrust suit against United States Gypsum Company (USG) and other gypsum producers, alleging violations of Sections 1 and 2 of the Sherman Antitrust Act through a conspiracy to fix prices on both patented and unpatented gypsum board via restrictive licensing agreements that restrained trade and maintained monopoly power.[35] USG, which controlled approximately 55% of the U.S. gypsum board market in 1939, had leveraged its patents on gypsum products to enforce uniform pricing across licensees, effectively eliminating competition in the eastern United States.[35] The U.S. Supreme Court ruled in 1948 that these practices constituted an illegal restraint of trade, rejecting the defense that patent rights justified price-fixing, and remanded the case for further proceedings on monopolization claims; a subsequent 1950 decision upheld findings of concerted action to fix prices.[36][37]
More recently, USG faced allegations in the multidistrict litigation In re Domestic Drywall Antitrust Litigation (filed starting in 2013), where direct and indirect purchasers accused major drywall manufacturers, including USG, of conspiring to fix prices and eliminate discounts from approximately 2008 to 2013, resulting in coordinated increases of up to 35% amid stable raw material costs.[38] USG settled these claims for $39.25 million in February 2015 with direct purchasers, denying liability but contributing to broader industry settlements exceeding $125 million, while certain claims against USG proceeded to trial before partial resolutions.[39] These proceedings highlighted recurring patterns of parallel pricing behavior among oligopolistic firms, scrutinized under federal antitrust laws for evidence of plus factors beyond mere conscious parallelism, such as communications facilitating coordination.[38]
The gypsum board industry exhibits high market concentration, with a handful of integrated producers controlling the majority of U.S. output due to substantial barriers to entry, including access to gypsum mining reserves, capital-intensive manufacturing facilities, and nationwide distribution networks.[35] Historically dominated by USG's patented innovations like SHEETROCK, the sector's structure—characterized by few competitors such as National Gypsum and CertainTeed—has fostered conditions prone to price coordination, as evidenced by repeated antitrust challenges rather than robust price competition driven by new entrants.[38] This oligopolistic dynamic persists amid steady demand from construction, with the U.S. gypsum board market valued at approximately $15.6 billion in 2023, underscoring how vertical integration and resource control amplify regulatory scrutiny over potential anticompetitive conduct.[40]
Asbestos Litigation and Tort Liabilities
USG Corporation, through its subsidiaries like United States Gypsum Company, incorporated asbestos fibers into various products including joint compounds, plasters, and fireproofing materials from the early 1900s until the 1970s, primarily to enhance fire resistance and durability in construction applications.[10] Exposure risks arose during manufacturing, installation, and maintenance, leading to health claims centered on diseases such as mesothelioma, lung cancer, and asbestosis among workers and end-users.[8]
Litigation intensified in the early 1990s, with over 45,000 claims filed by USG employees and their families alleging occupational exposure.[41] Between 1994 and 2001, the company faced more than 250,000 asbestos-related personal injury lawsuits, contributing to escalating defense costs and settlements exceeding $450 million before insurance recoveries.[8] These mass tort actions strained USG's finances despite ongoing profitability in core gypsum board operations, as liabilities accumulated from legacy product use predating modern regulatory bans on asbestos in building materials.[42]
To address the mounting claims, USG Corporation and 10 affiliates filed for Chapter 11 bankruptcy protection on June 25, 2001, in the U.S. Bankruptcy Court for the District of Delaware, explicitly citing asbestos personal injury obligations as the primary driver.[43] The filing aimed to equitably resolve present and future asbestos tort claims through a dedicated trust, insulating reorganized operations from further disruption.[7] A joint plan of reorganization, confirmed on October 5, 2006, established the United States Gypsum Asbestos Personal Injury Settlement Trust funded with approximately $4 billion, derived from equity issuance, insurance proceeds, and other contributions.[43][44]
The trust, operational since USG's emergence from bankruptcy, processes claims via expedited and individual reviews, with scheduled values ranging from $4,000 for non-malignant conditions to $30,000 for severe asbestosis, adjusted by an 11% payment percentage as of recent updates.[45][7] By channeling liabilities, the restructuring enabled USG to exit bankruptcy without canceling stock or debt, preserving value for non-asbestos stakeholders while compensating verified claimants.[44] Ongoing trust distributions continue to handle residual claims, reflecting the long latency of asbestos-related diseases.[42]